Cav-1 null mice are hyperphagic and have a normal capacity to absorb... | Download Scientific Diagram
ACKNOWLEDGEMENTS
Dr. Corinna Lantin – Projektmanager – Pharmalog Institut für klinische Forschung GmbH | LinkedIn
Sphingomyelin-enriched Microdomains at the Golgi Complex | Molecular Biology of the Cell
Christina Müller-Weisbrod – Dietzenbach, Hessen, Deutschland | Berufsprofil | LinkedIn
Sphingomyelin-enriched Microdomains at the Golgi Complex | Molecular Biology of the Cell
Ioannis Gkantiragas email address & phone number | GBG Forschungs GmbH Senior Clinical Project Manager, PMP contact information - RocketReach
Sphingomyelin-enriched Microdomains at the Golgi Complex | Molecular Biology of the Cell
Μάνος Τερζάκης - Electrical Engineer - Self-employed | LinkedIn
German Breast Group, Annual Scientific Report 2020
Sphingomyelin-enriched Microdomains at the Golgi Complex | Molecular Biology of the Cell
Quantitation of lipid content of various CHO compart- ments | Download Table
Histological analysis of adipose tissues from 12-week and 36week-old... | Download Scientific Diagram
A Putative Heterotrimeric G Protein Inhibits the Fusion of COPI-coated Vesicles - Journal of Biological Chemistry
Protein subcomplexes in the GIC preparation. Left, GICs were isolated... | Download Scientific Diagram
Dora KALOYANOVA | PhD | Utrecht University, Utrecht | UU | Department of Biochemistry and Cell Biology (DBC) | Research profile
Sphingomyelin-enriched Microdomains at the Golgi Complex | Molecular Biology of the Cell
Daniele Cordier-Stockmann email address & phone number | GBG Forschungs GMBH Accounting Assistant contact information - RocketReach
Konstantinos Pavlou on LinkedIn: EY Smart Daily Management
PDF) Sphingomyelin-enriched Microdomains at the Golgi Complex
German Breast Group, Annual Scientific Report 2020
A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE)☆ - ESMO Open
CAMBRIA-1-Studie zu Camizestrant bei HR+ / HER2-negativem Brustkrebs
A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE) - ScienceDirect
Xueyi LI | Partners HealthCare, Massachusetts | Department of Neurology | Research profile
Felix WIELAND | Head of Department | prof. Dr. rer. nat. dipl. Chem. | Universität Heidelberg, Heidelberg | Center for Biochemistry (BZH) | Research profile - Page 2
Ioannis Gkantiragas | LinkedIn
Thomai Gkantiraga på LinkedIn: I didn't expect that someone could be filled with so many memories and… | 18 kommentarer
